Amantadine revisited: an open trial of amantadinesulfate treatment in chronically depressed patients with Borna disease virus infection
by
Ferszt R, Kuhl KP, Bode L, Severus EW,
Winzer B, Berghofer A, Beelitz G,
Brodhun B, Muller-Oerlinghausen B, Ludwig H
Department of Gerontopsychiatry,
Freie Universitat Berlin, Germany.
ferszt@zedat.fu-berlin.de
Pharmacopsychiatry 1999 Jul;32(4):142-7

ABSTRACT

Amantadinesulfate is a well known substance which has proven useful in the treatment and prophylaxis of viral infections, in treating symptoms of Parkinson's disease, cocaine dependence, and apathy in multiple sclerosis. It has also been reported as having mild antidepressive effects not sufficient to warrant its use as an antidepressant. Striking antidepressive effects in some patients have been attributed to its antiviral activity against human Borna disease virus (BDV) infection which is frequently seen in patients with depressive episodes. In this 8 to 12 week open study of oral amantadine in 30 depressed patients with various states of BDV infection we found a significant antidepressive response in 19 of 30. Peripheral BDV antigen indicating acute infection was cleared in both responders and non-responders, but only in responders peripheral infection was significantly reduced.

MAO
NMDA
Opioids
Serotonin
Dopamine
Amantadine
Noradrenaline
Amantadine : structure
Amantadine-induced Othello syndrome
Amantadine (Symmetrel): prescribing information (PDF)

Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family